Premier Asset Management’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

Premier Asset Management’s Portfolio VBIV Stock Details VBIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-2,648	Closed	-$218K	–	211
2020 Q4	$218K	Buy	+2,648	New	+$226K	0.04%	165
2020 Q3	–	Sell	-1,126	Closed	-$105K	–	177
2020 Q2	$105K	Sell	1,126 -12,576	-92%	-$693K	0.04%	124
2020 Q1	$391K	Buy	13,702 +5,266	+62%	+$205K	0.16%	75
2019 Q4	$349K	Buy	+8,436	New	+$185K	0.11%	96

Other funds holding VBIV

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

GAI

General American Investors New York $1.69B AUM 40.94% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Premier Asset Management's VBIV Position: Q1 2021 in Review

Premier Asset Management sold out of VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) in Q1 2021, closing a stake of 2,648 shares — an estimated $218K sold.

Premier Asset Management first reported a position in VBIV in Q4 2019 and held it in 4 quarters. The position peaked at $391K in Q1 2020. 137 funds tracked by Wall St. Rank hold VBIV as of Q1 2021.

Premier Asset Management reported no remaining VBI Vaccines, Inc. New Common Stock (Canada) position as of Q1 2021 after selling out during the quarter.
Premier Asset Management sold 2,648 VBI Vaccines, Inc. New Common Stock (Canada) shares in Q1 2021, an estimated $218K.
Premier Asset Management first reported a position in VBI Vaccines, Inc. New Common Stock (Canada) in Q4 2019 and held it in 4 quarters.
Premier Asset Management's VBI Vaccines, Inc. New Common Stock (Canada) position peaked at $391K in Q1 2020.
137 funds tracked by Wall St. Rank held VBI Vaccines, Inc. New Common Stock (Canada) as of Q1 2021.

Based on Premier Asset Management's 13F filing for Q1 2021, filed 12 May 2021.